AbbVie Inc (ABBV)

Index:

S&P 100

$ 214.35
   
  • Change Today:
    $-2.40
  • 52 Week High: $244.38
  • 52 Week Low: $169.20
  • Currency: US Dollars
  • Shares Issued: 1,765.26m
  • Volume: 8,649,746
  • Market Cap: $378,383m
  • RiskGrade: 122
  • Beta: 0.01

Latest ShareCast News

AstraZeneca sells hypertension drug rights; Ends Allergan deal

By Frank Prenesti

Date: Monday 27 Jan 2020

(Sharecast News) - AstraZeneca said it had agreed to sell the global commercial rights to a range of hypertension treatments to Atnahs Pharma for up to $390m.

AbbVie Inc ShareCast News

Botox maker Allergan reports jump in third-quart... 05-Nov-2019 ShareCast
Abbvie snaps up Botox-maker Allergan in $63bn deal 25-Jun-2019 ShareCast
Pharma firms to testify in Congress over drug pr... 26-Feb-2019 ShareCast

AbbVie Inc Newspaper Links

Abbvie boss blasts US tax regime 21-Oct-2014 Telegraph
Drug company AbbVie takeover rival in £31bn bid 18-Jul-2014 Express & Star
AbbVie to announce firm bid for Shire 18-Jul-2014 Telegraph
AbbVie's raised proposal for Shire gets board ba... 15-Jul-2014 Guardian
Shire set to accept £31bn bid from US rival AbbVie 15-Jul-2014 Express & Star

AbbVie Inc Tips & Analysis

No recent information was found.

AbbVie Inc News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AbbVie Inc Market Data

Currency US Dollars
Share Price $ 214.35
Change Today $ -2.40
% Change -1.11 %
52 Week High $244.38
52 Week Low $169.20
Volume 8,649,746
Shares Issued 1,765.26m
Market Cap $378,383m
Beta 0.01
RiskGrade 122

Trades for 16-Jan-2026

Time Volume / Share Price
15:59 100 @ $214.32
15:59 100 @ $214.31
15:59 600 @ $214.31
15:59 100 @ $214.33
15:59 100 @ $214.32

Top of Page